# Dexamethasone vs Ondansetron After Cesarean Delivery

> **NCT05692245** · PHASE4 · COMPLETED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 100 (actual)

## Conditions studied

- Nausea and Vomiting, Postoperative
- Cesarean Section Complications

## Interventions

- **DRUG:** Ondansetron
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT05692245
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-30
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05692245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05692245, "Dexamethasone vs Ondansetron After Cesarean Delivery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05692245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*